Working… Menu

Intrathecal Rituximab in Progressive Multiple Sclerosis (EFFRITE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02545959
Recruitment Status : Completed
First Posted : September 10, 2015
Last Update Posted : October 3, 2019
University Hospital, Bordeaux
Information provided by (Responsible Party):
Dr Mickaël BONNAN, Centre Hospitalier de PAU